showForm Anti-Granulocyte macrophage colony stimulating factor (GM-CSF) (human) antibodies

Name:
Phone:
E-mail:
Message

GM-CSF | Granulocyte-macrophage colony-stimulating factor

IMS01-120-318  |  Clonality: Polyclonal  |  Host: Hen  |  Reactivity: Human

GM-CSF | Granulocyte-macrophage colony-stimulating factor in the group Antibodies for Human/Animal  / Human Proteins / Cancer at Agrisera AB (Antibodies for research) (IMS01-120-318)

DATA SHEET IN PDF

Qty: 
320
How to cite this product:
Product name, number (Agrisera, Sweden)

Datasheet Product citations Add review

Product Information

Immunogen

purified full length recombinant protein P04141

Host Chicken
Clonality Polyclonal
Purity Total IgY
Format Liquid in 0.9% NaCl, 0.1% sodium azide
Quantity 100 ĩl (10.7 mg/ml)
Storage Store at 4°C; make aliquots to avoid working with a stock. Please, remember to spin tubes briefly prior to opening them to avoid any losses that might occur from liquid material adhering to the cap or sides of the tubes.
Tested applications Total, purified IgY
Recommended dilution 1 : 1000-1 : 5 000 (ELISA), 1 : 1000-1 : 5 000 (WB)
Expected | apparent MW

16 kDa

Reactivity

Confirmed reactivity Human
Predicted reactivity Primates, Rat
Not reactive in No confirmed exceptions from predicted reactivity are currently known.

Application examples

Additional information

Additional information The IgY fraction is isolated by a two-step PEG precipitation. procedure followed by ammonium sulphate precipitation.
The antibody, in dilution 1: 1000, will detect 10 ng of GM-CSF in immunoblotting.

Related products

Related products

IMS01-119-316 | Granulocyte colony-stimulating factor

IMS06-119-317 | Granulocyte colony-stimulating factor, biotinylated antibody

Secondary antibodies

Background

Background

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes. Used in myeloid reconstitution following bone marrow transplant, bone marrow transplant engraftment failure or delay, mobilization and following transplantation of autologous peripheral blood progenitor cells, and following induction chemotherapy in older adults with acute myelogenous leukemia.

Product citations

Selected references

to be added when available